At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
Straumann VivOss +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Clinical Trial to Investigate the Capability of Straumann® VivOss™ Compared to Geistlich Bio-Oss® in Sinus Floor Augmentation
In Brief
A clinical study evaluating Straumann VivOss and Geistlich Bio-Oss for Healthy. Completed, enrolled 52 participants across 2 sites in 2 countries.
Detailed Summary
A randomized controlled clinical trial to investigate the capability of Straumann® VivOss™ compared to Geistlich Bio-Oss in sinus floor augmentation to demonstrate superiority of Straumann® VivOss™ compared to Geistlich Bio-Oss in regards to the ratio of newly formed bone to residual bone substitute.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedNov 2014
Primary CompletionOct 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedNov 11, 2014
Enrollment StartOct 1, 2014
Primary CompletionOct 1, 2017
Study CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 11.6 years ago
Interventions
Straumann VivOssdevice
Patients will receive Straumann VivOss for sinus augmentation.
Geistlich Bio-Ossdevice
Patients will receive Geistlich Bio-Oss for sinus augmentation.